The Cigna Group$271.10NTRA · NASDAQ-GS
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $2.31B | $1.70B | $1.08B | $820.22M | $625.49M | $391.00M | $302.33M | $257.65M |
| Cost of Revenue | — | — | — | — | — | — | — | $158.08M |
| Research & Development | $624.11M | $404.14M | $320.68M | $316.42M | $264.21M | $100.03M | $51.36M | $51.35M |
| Selling, General & Administrative | $1.18B | $841.31M | $618.31M | $588.59M | $511.03M | $303.63M | $206.18M | $154.87M |
| Operating Expenses | $2.62B | $1.92B | $1.53B | $1.36B | $1.09B | $607.28M | $418.62M | $372.28M |
| Operating Income | -$309.91M | -$222.29M | -$446.25M | -$541.04M | -$468.17M | -$216.28M | -$116.29M | -$114.63M |
| Interest Expense | $4.07M | $10.69M | $12.64M | $9.32M | $8.30M | $15.08M | $10.69M | $10.48M |
| Income Before Taxes | -$268.09M | -$189.73M | -$434.53M | -$546.82M | -$471.10M | -$229.65M | -$122.83M | -$127.83M |
| Provision for Income Taxes | -$59.93M | $695.00K | $271.00K | $978.00K | $618.00K | $98.00K | $2.00M | $321.00K |
| Net Income | -$208.16M | -$190.43M | -$434.80M | -$547.80M | -$471.72M | -$229.74M | -$124.83M | -$128.15M |
| Basic EPS | -$1.52 | -$1.53 | -$3.78 | -$5.57 | -$5.21 | -$2.84 | -$1.79 | -$2.22 |
| Diluted EPS | -$1.52 | -$1.53 | -$3.78 | -$5.57 | -$5.21 | -$2.84 | -$1.79 | -$2.22 |
| Basic Shares Outstanding | 136.72M | 124.72M | 115.00M | 98.41M | 90.56M | 81.01M | 69.56M | 57.85M |
| Diluted Shares Outstanding | 136.72M | 124.72M | 115.00M | 98.41M | 90.56M | 81.01M | 69.56M | 57.85M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | -$1.49 | -$1.84 | -$1.29 | 4 | ↑1 ↓0 |
| Dec 2027 | -$0.09 | -$0.30 | $0.18 | 4 | ↑0 ↓1 |
| Dec 2028 | $1.51 | $1.10 | $1.80 | 3 | ↑0 ↓0 |
